These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28879464)

  • 41. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration.
    Jacobs ML; Rychik J; Byrum CJ; Norwood WI
    Ann Thorac Surg; 1996 Jan; 61(1):206-8. PubMed ID: 8561554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fenestration of extracardiac fontan and reversal of protein-losing enteropathy: case report.
    Lemes V; Murphy AM; Osterman FA; Laschinger JC; Kan JS
    Pediatr Cardiol; 1998; 19(4):355-7. PubMed ID: 9636262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein-losing enteropathy in systemic lupus erythematosus. Diagnosis and monitoring immunosuppressive therapy by alpha-1-antitrypsin clearance in stool.
    Benner KG; Montanaro A
    Dig Dis Sci; 1989 Jan; 34(1):132-5. PubMed ID: 2783407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment strategies for protein-losing enteropathy in Fontan-palliated patients.
    Schleiger A; Ovroutski S; Peters B; Schubert S; Photiadis J; Berger F; Kramer P
    Cardiol Young; 2020 May; 30(5):698-709. PubMed ID: 32364090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of children with protein - losing enteropathy after fontan and other complex congenital heart disease procedures in condition with limited human and technical resources.
    Bejiqi R; Retkoceri R; Zeka N; Bejiqi H; Vuqiterna A; Maloku A
    Mater Sociomed; 2014 Feb; 26(1):39-42. PubMed ID: 24757400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein-losing enteropathy after the Fontan operation: successful treatment by percutaneous fenestration of the atrial septum.
    Warnes CA; Feldt RH; Hagler DJ
    Mayo Clin Proc; 1996 Apr; 71(4):378-9. PubMed ID: 8637261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein-Losing Enteropathy Following Fontan Palliation.
    Al Balushi A; Mackie AS
    Can J Cardiol; 2019 Dec; 35(12):1857-1860. PubMed ID: 31711823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful Treatment of Protein-Losing Enteropathy and Plastic Bronchitis by Biphasic Cuirass Ventilation in a Patient with Failing Fontan Circulation.
    Okada S; Muneuchi J; Nagatomo Y; Nonaka K; Iida C; Shirouzu H; Matsuoka R; Watanabe M; Joo K
    Int Heart J; 2018 Jul; 59(4):873-876. PubMed ID: 29794380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overlap of lymphatic dysplasia in Fontan-associated protein-losing enteropathy and Mucosa-Associated Lymphoid Tissue (MALT lymphoma): implications for management of protein-losing enteropathy.
    Meisner JK; Koblick S; Walling EB; Rabah R; Schumacher KR
    Cardiol Young; 2020 Dec; 30(12):1973-1975. PubMed ID: 33012302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation.
    Donnelly JP; Rosenthal A; Castle VP; Holmes RD
    J Pediatr; 1997 Mar; 130(3):474-8. PubMed ID: 9063428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards a proposal for a universal diagnostic definition of protein-losing enteropathy in Fontan patients: a systematic review.
    Udink Ten Cate FE; Hannes T; Germund I; Khalil M; Huntgeburth M; Apitz C; Brockmeier K; Sreeram N
    Heart; 2016 Jul; 102(14):1115-9. PubMed ID: 27033590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
    Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
    Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of circulating hepatocyte growth factor in protein-losing enteropathy after Fontan operation.
    Kim GB; Kwon BS; Bae EJ; Noh CI; Choi JY
    Pediatr Cardiol; 2011 Oct; 32(7):917-23. PubMed ID: 21667184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein-losing enteropathy and hypoalbuminemia in AIDS.
    Laine L; Garcia F; McGilligan K; Malinko A; Sinatra FR; Thomas DW
    AIDS; 1993 Jun; 7(6):837-40. PubMed ID: 8363760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure.
    Powell AJ; Gauvreau K; Jenkins KJ; Blume ED; Mayer JE; Lock JE
    Am J Cardiol; 2001 Nov; 88(10):1206-9. PubMed ID: 11703976
    [No Abstract]   [Full Text] [Related]  

  • 56. Protein-losing enteropathy in congestive cardiac failure: an entity of minor clinical significance.
    Berkowitz I; Segal I
    Am J Gastroenterol; 1990 Feb; 85(2):154-6. PubMed ID: 2301337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-losing enteropathy after fontan surgery: is assessment of risk patients with immunological data possible?
    Lenz D; Hambsch J; Schneider P; Tárnok A
    Cytometry B Clin Cytom; 2003 May; 53(1):34-9. PubMed ID: 12717689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal haemorrhage due to lymphangiectasia caused by protein-losing enteropathy in the Fontan circulation.
    Gras P; Gottrand F; Godart F
    Cardiol Young; 2017 Oct; 27(8):1641-1643. PubMed ID: 28651669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multiorgan malfunction after Fontan operation in adult patients].
    Smaś-Suska M; Iwaszczuk P; Róg B; Weryński P; Olszowska M; Podolec P; Tomkiewicz-Pająk L
    Pol Merkur Lekarski; 2017 Oct; 43(256):163-167. PubMed ID: 29084189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is faecal alpha 1-antitrypsin excretion a reliable screening test for protein-losing enteropathy?
    Haeney MR; Fields J; Carter RA; Thompson RA; Asquith P
    Lancet; 1979 Dec; 2(8153):1161-2. PubMed ID: 91891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.